Public health impact and economic benefits of quadrivalent influenza vaccine in Latin America

• Ngā kaituhi matua: Aurélien Jamotte (Author), Emilie Clay (Author), Bérengère Macabeo (Author), Andrès Caicedo (Author), Juan Guillermo Lopez (Author), Lucia Bricks (Author), Martín Romero Prada (Author), Rubén Marrugo (Author), Pamela Alfonso (Author), Brechla Moreno Arévalo (Author), Danilo Franco (Author), Lourdes Garcia Diaz (Author), Yadira Isaza de Molto (Author)
• Hōputu: Pukapuka
• I whakaputaina: Taylor & Francis Group, 2017-04-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Annual trivalent influenza vaccines (TIV) containing 2 A strains and one B lineage have been recommended for the prevention of influenza in most of Latin American countries. However, the circulation of 2 B lineages (Victoria and Yamagata) and difficulties in predicting the predominating lineage have...